Interestingly, interleukin serum levels appeared to vary in response to vasodilators: in a small cohort of SSc-PAH patients, a significant decrease in the serum levels of IL-2, IL-6, IL-8 and IFN-γ was observed after 12 months of treatment with bosentan [147]. The gene discussed is IL6; the disease is systemic sclerosis.